查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541342

2024-2032 年按技术、应用和地区分類的透皮给药系统市场报告

Transdermal Drug Delivery Systems Market Report by Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球透皮给药系统市场规模达67亿美元。

经皮给药系统（TDDS）是一种透过皮肤输送药物进行全身分布的替代系统。它被用作口腔血管内、皮下和跨黏膜途径的替代方案。 TDDS 可支援慢性和急性疾病以及美容手术，因为它可以透过皮肤输送药物和药妆品等生物活性剂。它提供药物的受控释放，从而减少首过代谢效应，减少副作用，并透过在整个治疗过程中实现稳定的血液药物分布来提高剂量的疗效。

透皮给药系统市场趋势：

全球透皮给药系统市场的主要驱动因素是无法透过传统给药系统（例如口服药物）治疗的慢性疾病的增加。患有糖尿病等长期疾病的患者正在转向自行用药。因此，人们引入了黏性皮肤贴片，以在没有疼痛的情况下进行日常用药。这鼓励患者和医生更喜欢无痛给药系统。除此之外，离子电渗疗法等第三代透皮给药系统的广泛采用可以促进患者的自力更生，因为它减少了频繁去医院的次数并减少了累积的治疗费用。此外，技术进步，例如微针的加入、透皮贴片设计的修改以及压敏黏合剂和渗透促进剂的加入，为製造商提供了巨大的机会。

本报告回答的关键问题：

  • 迄今为止，全球透皮给药系统市场表现如何，未来几年将如何表现？
  • COVID-19 对全球透皮给药系统市场有何影响？
  • 主要区域市场有哪些？
  • 基于技术的市场区隔是什么？
  • 基于应用的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球透皮给药系统市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球透皮给药系统市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依技术

  • 电穿孔
    • 市场趋势
    • 市场预测
  • 射频
    • 市场趋势
    • 市场预测
  • 离子电渗透疗法
    • 市场趋势
    • 市场预测
  • 微孔化
    • 市场趋势
    • 市场预测
  • 热的
    • 市场趋势
    • 市场预测
  • 机械阵列
    • 市场趋势
    • 市场预测
  • 超音波
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 中枢神经系统
    • 市场趋势
    • 市场预测
  • 疼痛管理
    • 市场趋势
    • 市场预测
  • 心血管
    • 市场趋势
    • 市场预测
  • 荷尔蒙
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Acrux Limited
    • Boehringer Ingelheim International GmbH
    • Hisamitsu Pharmaceutical Co. Inc.
    • Lavipharm SA
    • LEAD CHEMICAL Co. Ltd.
    • Luye Pharma Group
    • Nutriband Inc.
    • Viatris Inc.
Product Code: SR112024A3983

The global transdermal drug delivery systems market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

The transdermal drug delivery system (TDDS) is an alternative system of delivering drugs through the skin for systemic distribution. It is used as an alternative to oral intravascular, subcutaneous, and transmucosal routes. TDDS supports both chronic and acute diseases as well as cosmetic procedures as it delivers biologically active agents, such as drugs and cosmeceuticals, through the skin. It offers a controlled release of drugs, which reduces the first-pass metabolism effects, lessens the side effects, and improves the efficacy of the dosage by enabling a steady blood drug profile throughout the treatment.

Transdermal Drug Delivery System Market Trends:

The global transdermal drug delivery systems market is primarily driven by the growing instances of chronic disorders that cannot be treated through conventional drug delivery systems, such as oral drugs. Patients with long-term ailments, such as diabetes, are shifting toward self-administration of medicine. As a result, there has been an introduction of adhesive skin patches to administer the daily course of medication without the pain. This has encouraged patients and physicians to prefer pain-free drug delivery systems. Besides this, the wide adoption of third-generation transdermal drug delivery systems like iontophoresis promotes self-reliance in patients since it reduces frequent visits to hospitals and lessens the cumulative treatment costs. Furthermore, technological advancements, such as the inclusion of microneedles, modifications in transdermal patch designs and the incorporation of pressure-sensitive adhesives and permeation enhancers, are providing vast opportunities to manufacturers.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal drug delivery systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and application.

Breakup by Technology:

Electroporation

Radiofrequency

Iontophoresis

Microporation

Thermal

Mechanical Arrays

Ultrasound

Others

Breakup by Application:

Central Nervous System

Pain Management

Cardiovascular

Hormone

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global transdermal drug delivery systems market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transdermal drug delivery systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electroporation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiofrequency
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Iontophoresis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microporation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Thermal
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Mechanical Arrays
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ultrasound
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Central Nervous System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormone
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Acrux Limited
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boehringer Ingelheim International GmbH
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Hisamitsu Pharmaceutical Co. Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Lavipharm S.A.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LEAD CHEMICAL Co. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Luye Pharma Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nutriband Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Viatris Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials

List of Figures

  • Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
  • Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
  • Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
  • Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players